iSpecimen Inc.
ISPC
$1.55
-$0.04-2.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -92.11% | -87.25% | -79.24% | -67.73% | -43.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -92.11% | -87.25% | -79.24% | -67.73% | -43.77% |
| Cost of Revenue | -75.60% | -73.15% | -64.08% | -51.34% | -24.11% |
| Gross Profit | -126.18% | -109.83% | -99.40% | -85.50% | -63.36% |
| SG&A Expenses | -28.06% | -31.76% | -48.11% | -8.29% | -13.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -41.55% | -43.86% | -50.47% | -23.16% | -18.50% |
| Operating Income | 14.41% | 13.09% | 29.46% | -24.31% | -7.40% |
| Income Before Tax | -12.04% | 1.33% | 16.09% | -21.09% | 0.03% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.04% | 1.33% | 16.09% | -21.09% | 0.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.04% | 1.33% | 16.09% | -21.09% | 0.03% |
| EBIT | 14.41% | 13.09% | 29.46% | -24.31% | -7.40% |
| EBITDA | 13.60% | 12.85% | 30.09% | -24.89% | -7.16% |
| EPS Basic | 84.65% | 85.59% | 87.11% | 63.28% | 60.13% |
| Normalized Basic EPS | 84.65% | 85.59% | 87.11% | 63.28% | 60.13% |
| EPS Diluted | 84.65% | 85.59% | 87.11% | 63.28% | 60.13% |
| Normalized Diluted EPS | 84.65% | 85.59% | 87.11% | 63.28% | 60.13% |
| Average Basic Shares Outstanding | 1,149.82% | 530.39% | 545.99% | 444.92% | 244.40% |
| Average Diluted Shares Outstanding | 1,149.82% | 530.39% | 545.99% | 444.92% | 244.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |